Annette Clancy

Vorsitzender bei SWEDISH ORPHAN BIOVITRUM AB

Vermögen: 93 613 $ am 30.04.2024

70 Jahre

100 Beziehungen

Health Technology

Commercial Services

Consumer Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Jacky Vonderscher	M	69	OBSEVA SA ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	11 Jahre
Per Richard Torbjörn Hallberg	M	55	SWEDISH ORPHAN BIOVITRUM AB	6 Jahre
Vincent Lotteau	M	-	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	10 Jahre
Carole Deffez	F	-	LYSOGENE	5 Jahre
James Ford	M	-	GSK PLC	29 Jahre
Armin Reininger	M	67	SWEDISH ORPHAN BIOVITRUM AB	7 Jahre
Filippa Stenberg	F	-	SWEDISH ORPHAN BIOVITRUM AB	-
Helena Ildiko Saxon	F	54	SWEDISH ORPHAN BIOVITRUM AB	13 Jahre
Staffan Schüberg	M	55	SWEDISH ORPHAN BIOVITRUM AB	4 Jahre
Benoit de Chassey	M	-	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	10 Jahre
Jean-Jacques Garaud	M	68	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	10 Jahre
Peter Lichtlen	M	56	LYSOGENE	6 Jahre
Guido Oelkers	M	59	SWEDISH ORPHAN BIOVITRUM AB	7 Jahre
Patrice André	M	-	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	10 Jahre
Laurène Meyniel-Schickl	F	-	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	10 Jahre
Sven Anders Ullman	M	68	SWEDISH ORPHAN BIOVITRUM AB	3 Jahre
Timothy M. Wright	M	69	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	-
Henrik Stenqvist	M	57	SWEDISH ORPHAN BIOVITRUM AB	6 Jahre
Sally Jackson	F	-	GSK PLC	23 Jahre
Mahmood Ladha	M	60	SWEDISH ORPHAN BIOVITRUM AB	5 Jahre
Pablo de Mora	M	56	SWEDISH ORPHAN BIOVITRUM AB	5 Jahre
Christine Wesström	F	49	SWEDISH ORPHAN BIOVITRUM AB	14 Jahre
Lydia Abad-Franch	M	-	SWEDISH ORPHAN BIOVITRUM AB	-
Daniel Rankin	M	44	SWEDISH ORPHAN BIOVITRUM AB	7 Jahre
Ralph Laufer	M	-	LYSOGENE	6 Jahre
Norbert Oppitz	M	57	SWEDISH ORPHAN BIOVITRUM AB	7 Jahre
Jason Robert Dinges	M	48	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	-
Laurent Arthaud	M	61	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	4 Jahre
Lena Bjurner	F	56	SWEDISH ORPHAN BIOVITRUM AB	1 Jahre
Laurent Higueret	M	-	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	-
Eric Meldrum	M	-	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	-
David Redfern	M	57	GSK PLC	30 Jahre
Maina Bhaman	M	52	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	-
Iain Dukes	M	65	ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.	6 Jahre
Graham Rivers	M	-	GSK PLC	26 Jahre

Mehr sehen

Beziehungs-Chart

Beziehungen zu mehreren Unternehmen

Ehemalige Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Bo Jesper Hansen	M	66	SWEDISH ORPHAN BIOVITRUM AB	9 Jahre
Rafaèle Elisabeth Tordjman	M	54	LYSOGENE OBSEVA SA	8 Jahre
Fabien de Ladonchamps	M	45	OBSEVA SA	9 Jahre
Moncef Slaoui	M	64	GSK PLC	11 Jahre
Frank Verwiel	M	62	OBSEVA SA	6 Jahre
Ahmad Mortazavi	M	53	SILENCE THERAPEUTICS PLC	6 Jahre
Olav Hellebø	M	59	WEIFA ASA	3 Jahre
Wills Hughes-Wilson	F	53	SWEDISH ORPHAN BIOVITRUM AB	6 Jahre
Martin Nes	M	55	WEIFA ASA	-
Kristin Strandberg	F	35	SWEDISH ORPHAN BIOVITRUM AB	-
Katja Buhrer	F	-	OBSEVA SA	1 Jahre
William Brown	M	42	OBSEVA SA	1 Jahre
Hilde Furberg	F	65	WEIFA ASA	1 Jahre
Robert Spiegel	M	73	WEIFA ASA	-
William Louv	M	-	GSK PLC	21 Jahre
Catarina Edfjäll	M	59	OBSEVA SA	3 Jahre
Sven Håkan Björklund	M	68	SWEDISH ORPHAN BIOVITRUM AB	7 Jahre
David S. Schilansky	M	48	LYSOGENE	6 Jahre
Cameron McDonough	M	53	SWEDISH ORPHAN BIOVITRUM AB	6 Jahre
Hilde Hermansen Steineger	M	58	WEIFA ASA	6 Jahre
Anthony David Sedgwick	M	68	SILENCE THERAPEUTICS PLC	2 Jahre
Andrew Humberstone	M	-	OBSEVA SA	-
Philippe Pierre Goupit	M	-	LYSOGENE	-
Johannes G. C. P. Schikan	M	66	SWEDISH ORPHAN BIOVITRUM AB	9 Jahre
Murray Stewart	M	63	GSK PLC	17 Jahre
Patrick J. T. Vallance	M	64	GSK PLC	-
Roy Anderson	M	76	GSK PLC	11 Jahre
Thomas Kudsk Larsen	M	50	SWEDISH ORPHAN BIOVITRUM AB	2 Jahre
Lena Elisabeth Svanberg	M	63	SWEDISH ORPHAN BIOVITRUM AB	-
Theresa Heggie	F	63	SWEDISH ORPHAN BIOVITRUM AB	1 Jahre
Olivier Danos	M	66	LYSOGENE	9 Jahre
Barbara A. Ruskin	M	-	SILENCE THERAPEUTICS PLC	-
David Allsop	M	-	SWEDISH ORPHAN BIOVITRUM AB	-
Stephanie Burns	M	69	GSK PLC	9 Jahre
Stina Margareta Gestrelius	M	75	WEIFA ASA	-
Philip Haworth	M	68	SILENCE THERAPEUTICS PLC	1 Jahre
John David Coombe	M	79	GSK PLC	5 Jahre
Maxine Gowen	M	66	GSK PLC	13 Jahre
Barbara Duncan	F	59	OBSEVA SA	5 Jahre
Jean-Pierre Garnier	M	75	GSK PLC	8 Jahre
H. Culp	M	60	GSK PLC	9 Jahre
Jeremy Curnock-Cook	M	75	SILENCE THERAPEUTICS PLC	-
Robert P. Roche	M	68	GSK PLC	-
James Healy	M	58	OBSEVA SA	8 Jahre
Deryck Charles Maughan	M	76	GSK PLC	12 Jahre
Anders Paul Wiklund	M	84	WEIFA ASA	3 Jahre
Robert Wilson	M	81	GSK PLC	11 Jahre
Christopher Gent	M	75	GSK PLC	11 Jahre
Richard Sykes	M	79	GSK PLC	7 Jahre
Michèle Barzach	M	-	GSK PLC	7 Jahre
Peter Traber	M	69	GSK PLC	3 Jahre
Crispin Davis	M	75	GSK PLC	10 Jahre
Tom de Swaan	M	78	GSK PLC	9 Jahre
Iain Ross	M	71	SILENCE THERAPEUTICS PLC	6 Jahre
John Melvyn Davies	M	68	SILENCE THERAPEUTICS PLC	14 Jahre
Jeremy Randall	M	60	SILENCE THERAPEUTICS PLC	5 Jahre
Thomas Christély	M	-	SILENCE THERAPEUTICS PLC	-
Alex Howarth	M	55	GSK PLC	10 Jahre
Ed Mathers Mathers	M	64	OBSEVA SA	8 Jahre
Julian Heslop	M	70	GSK PLC	13 Jahre
Christopher Viehbacher	M	64	GSK PLC	20 Jahre
Brian O'Callaghan	M	54	OBSEVA SA	3 Jahre
Paula Treutiger	F	57	SWEDISH ORPHAN BIOVITRUM AB	3 Jahre
Max Herrmann	M	-	SILENCE THERAPEUTICS PLC	2 Jahre
Robert Carr	M	-	GSK PLC	26 Jahre

Statistik

Land	Beziehungen	% des Gesamten
Vereinigtes Königreich	37	37,00%
Schweden	26	26,00%
Frankreich	20	20,00%
Schweiz	12	12,00%
Norwegen	7	7,00%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen

Börse
Insiders
Annette Clancy
Persönliches Netzwerk